Article Versions Notes

Khramchikhin AV, Skryl’nikova MA, Esaulkova IL, Sinegubova EO, Zarubaev VV, Gureev MA, Puzyk AM, Ostrovskii VA. Novel [1,2,4]triazolo[3,4-b][1,3,4]thiadiazine and [1,2,4]triazolo[3,4-b][1,3,4]thiadiazepine Derivatives: Synthesis, Anti-Viral In Vitro Study and Target Validation Activity. Molecules. 2022; 27(22):7940. https://doi.org/10.3390/molecules27227940

Khramchikhin, Andrey V., Mariya A. Skryl’nikova, Iana L. Esaulkova, Ekaterina O. Sinegubova, Vladimir V. Zarubaev, Maxim A. Gureev, Aleksandra M. Puzyk, and Vladimir A. Ostrovskii. 2022. "Novel [1,2,4]triazolo[3,4-b][1,3,4]thiadiazine and [1,2,4]triazolo[3,4-b][1,3,4]thiadiazepine Derivatives: Synthesis, Anti-Viral In Vitro Study and Target Validation Activity" Molecules 27, no. 22: 7940. https://doi.org/10.3390/molecules27227940

Khramchikhin, A. V., Skryl’nikova, M. A., Esaulkova, I. L., Sinegubova, E. O., Zarubaev, V. V., Gureev, M. A., Puzyk, A. M., & Ostrovskii, V. A. (2022). Novel [1,2,4]triazolo[3,4-b][1,3,4]thiadiazine and [1,2,4]triazolo[3,4-b][1,3,4]thiadiazepine Derivatives: Synthesis, Anti-Viral In Vitro Study and Target Validation Activity. Molecules, 27(22), 7940. https://doi.org/10.3390/molecules27227940